Vitaspring Biomedical Co. Ltd. (VSBC)
VSBC is quoted over the counter, not listed on an exchange. Vitaspring Biomedical Co. Ltd. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | VSBC, quoted over the counter |
| SEC CIK | 0001697884 |
| OTC Markets tier | OTCID (price source, 2026-11-13) |
| SEC industry code | Services-Commercial Physical & Biological Research |
| Business address | Riverside, CA |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about our ability to continue as a going concern within one year from the issuance of these financial statements." | 10-Q 2026-09-17 |
| Cash and burn | $13K cash; operating cash flow $3K a quarter. | Report 2026-07-31 |
| Shares outstanding | 207,030,030 (2026-09-14); 207,030,030 a year earlier. | Cover page 2026-09-14 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | JP CENTURION & PARTNERS PLT, Kuala Lumpur, Malaysia; changed auditors 2 times in 24 months | 8-K 4.01 2025-08-25 |
| Late filings, 12 months | 1 NT notice | NT 10-Q 2026-09-15 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-07-31 | $0 | -$156K | $5K | $13K | $2.4M | $0 | 10-Q 2026-09-17 |
| Q1 2027 2026-04-30 | $0 | -$76K | $6K | $8K | No debt tags | $0 | 10-Q 2026-06-17 |
| Q4 2026 2026-01-31 | $0 | -$81K | $124 | $2K | $0 | $0 | 10-K 2026-06-17 |
| Q3 2026 2025-10-31 | $0 | -$143K | -$839 | $0 | No debt tags | $0 | 10-Q 2026-06-17 |
| Q2 2026 2025-07-31 | $0 | -$111K | -$1K | $0 | No debt tags | $0 | 10-Q 2026-09-17 |
| Q1 2026 2025-04-30 | $0 | -$81K | -$787 | $0 | No debt tags | $0 | 10-Q 2026-06-17 |
| Q4 2025 2025-01-31 | $0 | -$143K | -$2K | $0 | No debt tags | $0 | 10-K 2026-06-17 |
| Q3 2025 2024-10-31 | $0 | -$196K | -$6K | $2K | No debt tags | $0 | 10-Q 2026-06-17 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2017-06-07 |
| Latest annual report | 10-K | 2026-06-17 |
| Latest quarterly / interim | 10-Q | 2026-09-17 |
| Latest current report | 8-K | 2026-09-10 |
Source: SEC EDGAR submissions feed, 74 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier